| 专论编号 | 物质名称 | 证书持有人 | 持有人ORG-ID和LOC-ID | 证书编号 | 发布日期 | 证书状态 | 到期续期 | 证书结束日期 | 证书类型 | 上一程序的结束日期 | 历史数据 程序类型|结论|日期 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2229 | Enrofloxacin for veterinary use, Process II | MATRIX PHARMACORP PRIVATE LIMITED Sangareddy District IN | 100051463;100098142 | CEP 2023-424 - Rev 02 | 2025/09/24 | Valid | 14/02/2029 | Chemical | 2025/09/24 | Notification|CEP granted|24/09/2025; Notification|CEP granted|29/07/2024; New application|CEP granted|14/02/2024 |
|
| 1250 | Omega-3-acid ethyl esters 90, With alpha-tocopherol 2 | SHANDONG TENMORE TRADING CO., LTD. Linyi CN | 100051725;100090854 | CEP 2025-341 - Rev 00 | 2025/09/24 | Valid | 24/09/2030 | Chemical | 2025/09/24 | New application|CEP granted|24/09/2025 | |
| 2125 | Doxazosin mesilate | NIFTY LABS PRIVATE LIMITED Hyderabad IN | 100014767;100042749 | CEP 2022-257 - Rev 01 | 2025/09/24 | Valid | 15/04/2029 | Chemical | 2025/09/24 | Notification|CEP granted|24/09/2025; New application|CEP granted|15/04/2024 |
|
| 2932 | Rivaroxaban | NIFTY LABS PRIVATE LIMITED Hyderabad IN | 100014767;100042749 | CEP 2022-375 - Rev 01 | 2025/09/24 | Valid | 17/05/2029 | Chemical | 2025/09/24 | Notification|CEP granted|24/09/2025; New application|CEP granted|17/05/2024 |
|
| 2541 | Quetiapine Fumarate, Process II | NIFTY LABS PRIVATE LIMITED Hyderabad IN | 100014767;100042749 | CEP 2021-289 - Rev 04 | 2025/09/24 | Valid | 01/04/2027 | Chemical | 2025/09/24 | Notification|CEP granted|24/09/2025; Minor revision|CEP granted|14/05/2024; Minor revision|CEP granted|15/06/2023; Notification|CEP granted|16/08/2022; New application|CEP granted|01/04/2022 |
|
| 253 | Ascorbic acid | Luwei Pharmaceutical Group Co., Ltd Zibo CN | 100049996;100087293 | CEP 2023-408 - Rev 00 | 2025/09/24 | Valid | 24/09/2030 | Chemical and TSE | 2025/09/24 | New application|CEP granted|24/09/2025 | |
| 2230 | Latanoprost | CAYMAN PHARMA S.R.O. Neratovice CZ | 100013822;100019767 | CEP 2023-147 - Rev 01 | 2025/09/23 | Valid | 10/06/2030 | Chemical | 2025/09/23 | Administrative procedure|CEP granted|23/09/2025; New application|CEP granted|10/06/2025 |
|
| 2787 | Esomeprazole magnesium dihydrate, Micronised 1 and Micronised 2 | CIPLA LIMITED Mumbai IN | 100006004;100018147 | CEP 2014-077 - Rev 02 | 2025/09/23 | Valid | Chemical | 2025/09/23 | Minor revision|CEP granted|23/09/2025; Minor revision|CEP granted|21/11/2024; Renewal|CEP granted|26/08/2021 |
||
| 2616 | Topiramate | ZYDUS LIFESCIENCES LIMITED Vadodara IN | 100005979;100074301 | CEP 2021-419 - Rev 02 | 2025/09/23 | Valid | 24/03/2028 | Chemical | 2025/09/23 | Minor revision|CEP granted|23/09/2025; Minor revision|CEP granted|10/10/2024; New application|CEP granted|24/03/2023 |
|
| 2600 | Olmesartan medoxomil | MATRIX PHARMACORP PRIVATE LIMITED Sangareddy District IN | 100051463;100098142 | CEP 2012-043 - Rev 05 | 2025/09/23 | Valid | Chemical | 2025/09/23 | Notification|CEP granted|23/09/2025; Notification|CEP granted|22/07/2024; Notification|CEP granted|01/09/2021; Major revision|CEP granted|02/11/2020 |
||
| 2787 | Esomeprazole magnesium dihydrate, Micronised, non-micronised | MINAKEM Dunkerque FR | 100032366;100056463 | CEP 2015-086 - Rev 01 | 2025/09/22 | Valid | Chemical | 2025/09/22 | Major revision|CEP granted|22/09/2025; Notification|Accepted - CEP remains valid|15/11/2024; Minor revision|Accepted - CEP remains valid|20/12/2023; Minor revision|Accepted - CEP remains valid|15/07/2022; Minor revision|Accepted - CEP remains valid|26/05/2021; Renewal|CEP granted|31/08/2020 |
||
| 1563 | Simvastatin, Ethanol process | TAPI NL B.V. Amsterdam NL | 100003852;100094134 | CEP 2010-130 - Rev 06 | 2025/09/22 | Valid | Chemical | 2025/09/22 | Notification|CEP granted|22/09/2025; Notification|CEP granted|20/12/2021 |
||
| 929 | Loperamide hydrochloride, Micronised | LAKE CHEMICALS PRIVATE LIMITED Bengaluru IN | 100012055;100053935 | CEP 2009-362 - Rev 03 | 2025/09/22 | Valid | Chemical | 2025/09/22 | Minor revision|CEP granted|22/09/2025; Notification|CEP granted|14/02/2023 |
||
| 2675 | Irinotecan hydrochloride trihydrate | QILU PHARMACEUTICAL CO., LTD. Jinan CN | 100014051;100061315 | CEP 2016-276 - Rev 02 | 2025/09/22 | Valid | Chemical | 2025/09/22 | Major revision|CEP granted|22/09/2025; Minor revision|Accepted - CEP remains valid|31/01/2025; Minor revision|CEP granted|26/06/2024; Minor revision|Accepted - CEP remains valid|26/02/2024; Renewal|CEP granted|25/08/2022; Notification|Accepted - CEP remains valid|28/01/2022; Notification|Accepted - CEP remains valid|10/11/2021; Notification|CEP granted|16/09/2021; Minor revision|CEP granted|19/06/2020 |
||
| 2423 | Valsartan | IPCA LABORATORIES LIMITED Mumbai IN | 100011685;100018680 | CEP 2010-100 - Rev 06 | 2025/09/22 | Valid | Chemical | 2025/09/22 | Minor revision|CEP granted|22/09/2025; Minor revision|CEP granted|18/11/2022; Minor revision|Accepted - CEP remains valid|15/06/2022; Minor revision|CEP granted|01/12/2020; Minor revision|Accepted - CEP remains valid|19/05/2020 |
||
| 1442 | Leuprorelin | CHEMI S.P.A. Patrica IT | 100000347;100009242 | CEP 2008-115 - Rev 05 | 2025/09/22 | Valid | Chemical | 2025/09/22 | Minor revision|CEP granted|22/09/2025; Minor revision|CEP granted|10/03/2022; Notification|Rejected|30/11/2021; Minor revision|Accepted - CEP remains valid|28/05/2020 |
||
| 533 | Triamcinolone acetonide | AVIK PHARMACEUTICAL LIMITED Vapi IN | 100023327;100041968 | CEP 2018-231 - Rev 01 | 2025/09/22 | Valid | Chemical | 2025/09/22 | Renewal|CEP granted|22/09/2025; Notification|Accepted - CEP remains valid|17/06/2022 |
||
| 687 | Salbutamol sulfate, Micronised | MELODY HEALTHCARE PRIVATE LIMITED Mumbai IN | 100014822;100073679 | CEP 2020-063 - Rev 03 | 2025/09/22 | Valid | Chemical | 2025/09/22 | Renewal|CEP granted|22/09/2025; Monograph revision|CEP granted|25/03/2024; Minor revision|CEP granted|23/03/2022; New application|CEP granted|21/10/2020 |
||
| 2333 | Fluvastatin sodium, Crystalline-2 | BIOCON LIMITED Bengaluru IN | 100011487;100018595 | CEP 2022-130 - Rev 02 | 2025/09/22 | Valid | 15/06/2027 | Chemical | 2025/09/22 | Minor revision|CEP granted|22/09/2025; Administrative procedure|CEP granted|23/06/2022; New application|CEP granted|15/06/2022 |
|
| 1300 | Cefuroxime axetil, Amorphous | TITAN PHARMACEUTICAL CO., LTD. (GUANGDONG) Heyuan City CN | 100024682;100033865 | CEP 2017-034 - Rev 01 | 2025/09/22 | Valid | Chemical | 2025/09/22 | Minor revision|CEP granted|22/09/2025; Renewal|CEP granted|20/04/2023; Minor revision|CEP granted|02/09/2021; Minor revision|CEP granted|23/04/2021 |
请输入需要查询的英文物质名称,证书持有人,证书编号,专论编号